ENTEROME Trademark

Trademark Overview


On Thursday, January 3, 2013, a trademark application was filed for ENTEROME with the United States Patent and Trademark Office. The USPTO has given the ENTEROME trademark a serial number of 79126292. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, April 22, 2025. This trademark is owned by ENTEROME. The ENTEROME trademark is filed in the Chemical Products, Cosmetics & Cleaning Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

[ Cosmetic products, namely, cosmetic creams ]

Human pharmaceutical research; research services provided by a pharmaceutical laboratory, namely, providing medical research testing services in the field of metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation, and irritable bowel syndrome; Providing medical and scientific research information in the field of metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation, and irritable bowel syndrome; providing medical and scientific research information in the field of pharmaceutical and clinical trials; scientific laboratory services, genetic testing of laboratory animals for pharmaceutical research purposes; biological research in the fields of microbiology and chemistry

Pharmaceutical and medicinal products for human and veterinary use, namely, pharmaceutical preparations for treating metabolic disorders, immunological disorders, cancers, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome; veterinary products, namely, anti-infective products for veterinary use, veterinary pharmaceutical preparations for treatment of metabolic disorders, immunological disorders, cancers, central nervous systems disorders, gastroenterological disorders, infectious diseases and diarrhea; medicinal products for human and veterinary use, namely, nutritional supplements containing probiotic compositions; sanitary products for use in medicine, namely, sanitary sterilizing preparations, disinfectants for sanitary purposes, sanitary preparations for medical use; dietetic food and substances for medical use in the nature of meal replacement products and prepackaged meal plans, namely, nutrit...

[ Chemical and biochemical substances used for the manufacture and preservation of foodstuffs, of pharmaceutical, cosmetic and veterinary products, namely, probiotic bacteria and probiotic bacterial cultures for use in the manufacture of food products and pharmaceutical preparations, prebiotic bacteria and prebiotic bacterial cultures for use in the manufacture of food products and pharmaceutical preparations, enzymes for use in the manufacture of food products and pharmaceutical preparations ]
enterome

General Information


Serial Number79126292
Word MarkENTEROME
Filing DateThursday, January 3, 2013
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, April 22, 2025
Registration Number4561761
Registration DateTuesday, July 8, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2014

Trademark Statements


Goods and Services[ Cosmetic products, namely, cosmetic creams ]
Goods and ServicesHuman pharmaceutical research; research services provided by a pharmaceutical laboratory, namely, providing medical research testing services in the field of metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation, and irritable bowel syndrome; Providing medical and scientific research information in the field of metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation, and irritable bowel syndrome; providing medical and scientific research information in the field of pharmaceutical and clinical trials; scientific laboratory services, genetic testing of laboratory animals for pharmaceutical research purposes; biological research in the fields of microbiology and chemistry
Goods and ServicesPharmaceutical and medicinal products for human and veterinary use, namely, pharmaceutical preparations for treating metabolic disorders, immunological disorders, cancers, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome; veterinary products, namely, anti-infective products for veterinary use, veterinary pharmaceutical preparations for treatment of metabolic disorders, immunological disorders, cancers, central nervous systems disorders, gastroenterological disorders, infectious diseases and diarrhea; medicinal products for human and veterinary use, namely, nutritional supplements containing probiotic compositions; sanitary products for use in medicine, namely, sanitary sterilizing preparations, disinfectants for sanitary purposes, sanitary preparations for medical use; dietetic food and substances for medical use in the nature of meal replacement products and prepackaged meal plans, namely, nutritional meal replacement bars adapted for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome, prepared, prepackaged entrees for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome, prepared, prepackaged snack foods for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome, prepared, prepackaged yogurts for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome, prepared, prepackaged desserts for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome; nutritional supplements for medical use; food additives for medical use, namely, dietary fiber for treating metabolic disorders, gastroenterological disorders, diarrhea, constipation and irritable bowel syndrome; nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables, microorganisms and crops
Goods and Services[ Chemical and biochemical substances used for the manufacture and preservation of foodstuffs, of pharmaceutical, cosmetic and veterinary products, namely, probiotic bacteria and probiotic bacterial cultures for use in the manufacture of food products and pharmaceutical preparations, prebiotic bacteria and prebiotic bacterial cultures for use in the manufacture of food products and pharmaceutical preparations, enzymes for use in the manufacture of food products and pharmaceutical preparations ]

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, February 10, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, February 10, 2021
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 11, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 11, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameENTEROME
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPARIS F75011
FR

Party NameENTEROME
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPARIS F75011
FR

Party NameENTEROME
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPARIS F75011
FR

Trademark Events


Event DateEvent Description
Thursday, March 7, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, March 11, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 15, 2013APPLICATION FILING RECEIPT MAILED
Wednesday, April 17, 2013ASSIGNED TO EXAMINER
Friday, April 19, 2013NON-FINAL ACTION WRITTEN
Saturday, April 20, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, April 22, 2013REFUSAL PROCESSED BY MPU
Monday, April 22, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 15, 2013REFUSAL PROCESSED BY IB
Tuesday, October 22, 2013EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 22, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, October 22, 2013EXAMINERS AMENDMENT MAILED
Thursday, November 7, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 2, 2013ASSIGNED TO LIE
Friday, December 6, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 25, 2013NOTICE OF PUBLICATION
Wednesday, December 25, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 25, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, January 11, 2014NOTIFICATION PROCESSED BY IB
Tuesday, January 14, 2014PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2014EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, May 30, 2014EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, July 8, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, October 8, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, December 4, 2014FINAL DISPOSITION PROCESSED
Thursday, December 4, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 23, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, December 29, 2020TEAS SECTION 71 & 15 RECEIVED
Wednesday, February 10, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 10, 2021REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Wednesday, February 10, 2021NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Sunday, October 10, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, November 4, 2021INVALIDATION PROCESSED
Thursday, November 4, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, December 12, 2021PARTIAL INVALIDATION PROCESSED BY THE IB
Thursday, January 26, 2023INTERNATIONAL REGISTRATION RENEWED
Saturday, July 8, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Monday, December 9, 2024TEAS SECTION 71 RECEIVED
Monday, April 21, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 22, 2025REGISTERED-SEC.71 ACCEPTED
Tuesday, April 22, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, December 22, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED